Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non–small cell lung cancer

Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non–small cell lung cancer

Treatment challenges persist in advanced lung cancer despite the development of therapies beyond the traditional platinum-based chemotherapy. The early 2000s marked a shift to tyrosine kinase inhibitors targeting epidermal growth factor receptor, ushering in personalized genetic-based treatment. A f...

Full description

Bibliographic Details
Main Authors: Uiju Cho, Soyoung Im, Hyung Soon Park
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2024-03-01
Series:Journal of Pathology and Translational Medicine
Subjects:
non-small cell lung carcinoma
immune-checkpoint inhibitor
biomarkers
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-2024-01-31.pdf

Similar Items

Similar Items